Logo image
Back
Utility of Positron Emission Tomography in Radiotherapy Practice with Emphasis on Head and Neck Cancer
Journal article   Open access   Peer reviewed

Utility of Positron Emission Tomography in Radiotherapy Practice with Emphasis on Head and Neck Cancer

J. E. Bayouth, Y. Menda and M. M. Graham
Imaging decisions MRI, Vol.12(1), pp.14-24
03/2008
DOI: 10.1111/j.1617-0830.2008.00119.x
url
https://doi.org/10.1111/j.1617-0830.2008.00119.xView
Published (Version of record) Open Access

Abstract

Several issues related to functional imaging in treatment planning and response assessment in head and neck cancer exist. In the pre-radiotherapy setting, integrated positron emission tomography (PET)-computed tomography (CT) provides more accurate delineation of disease extent in head and neck cancer than does PET or CT alone, while fluorodeoxyglucose (FDG)-PET shows promise in detecting distant metastases and/or primary tumour after a negative work-up. Incorporating FDG-PET data during the radiotherapy planning stage may significantly alter the gross tumour volume as well as identify primary tumour sites. Given sufficient time following radiation therapy (RT), FDG-PET is valuable in identifying residual tumours where CT and/or magnetic resonance imaging are unable to. While FDG-PET and PET-CT show great potential, challenges exist in successfully integrating the data into radiotherapy planning. No integrated system is used throughout the planning and treatment delivery process, leading to difficulty in reconciling imaged data with accurate radiotherapy delivery. This is particularly true when attempting to accurately delineate the tumour boundary. Although the several discussed methods yield good results, target volume definition remains elusive and uncertain. By identifying targets using mathematical thresholding techniques some of this uncertainty is removed.
 Nuclear Medicine FDG-PET FLT-PET head and neck cancer radiation therapy treatment planning

Details

Metrics

7 Record Views
Logo image